Pharmaceuticals Archives - EMMA International

Aduhelm, an Accelerated Approval for Alzheimer’s

Alzheimer’s disease is the most common cause of dementia, especially in patients aged 65 and older1. Alzheimer’s...

Starting in Summer 2021, a new type of COVID vaccine could be available. Known as a protein subunit vaccine, this...

June 1 started the celebration of Pride Month, which commemorates Lesbian, Gay, Bisexual, and Transgender members....

Biocompatibility is one of the most critical performance studies that manufacturers need to perform as part of their...

Deciding how and when to conduct stability tests on your new drug can be challenging. Stability tests provide evidence...

With healthcare facing new challenges every day, it is important for us to stop and highlight these frontline heroes...

Today marks the 52nd anniversary of the birth of the true modern environmental movement, however, you probably know it...

2021 is shaping up to be a big year for MedTech mergers and acquisitions. Last week, Siemens Healthineers and Varian...

FDA launched the ASCA Pilot on September 25, 2020. This pilot would grant ASCA recognition to qualified accreditation...

Breaking news hit early this week regarding potential problems with Johnson & Johnson’s one-shot COVID vaccine,...

As we face the most challenging public health crises of our lifetimes, celebrating and thanking all those who serve...

Cell therapies are regulated as biologics under the Center for Biologics Evaluation and Research division of the FDA....